Correale, P., Tagliaferri, P., Del Vecchio, M.T., Remondo, C., Migali, C., Tsang, K.Y., et al. (2009). Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.. In Journal of Clinical Oncology (pp.140S).

Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.

FULFARO, Fabio;
2009-01-01

2009
ASCO MEETING 2009
2009
1
Correale, P., Tagliaferri, P., Del Vecchio, M.T., Remondo, C., Migali, C., Tsang, K.Y., et al. (2009). Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.. In Journal of Clinical Oncology (pp.140S).
Proceedings (atti dei congressi)
Correale, P; Tagliaferri, P; Del Vecchio, MT; Remondo, C; Migali, C; Tsang, KY; Rotundo, MS; Fulfaro, F; Tassone, P; Francini, G
File in questo prodotto:
File Dimensione Formato  
asco2009.mht

Solo gestori archvio

Dimensione 266.91 kB
Formato Unknown
266.91 kB Unknown   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/44442
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact